12-4912055-C-G
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000217.3(KCNA1):c.677C>G(p.Thr226Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T226K) has been classified as Pathogenic.
Frequency
Consequence
NM_000217.3 missense
Scores
Clinical Significance
Conservation
Publications
- episodic ataxia type 1Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Ambry Genetics, ClinGen, Orphanet, Genomics England PanelApp, Labcorp Genetics (formerly Invitae)
- episodic kinesigenic dyskinesia 1Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- isolated autosomal dominant hypomagnesemia, Glaudemans typeInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- genetic developmental and epileptic encephalopathyInheritance: AR, AD Classification: SUPPORTIVE, LIMITED Submitted by: G2P, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome Cov.: 35
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Episodic ataxia type 1 Pathogenic:2Other:1
- -
- -
This variant has been previously reported in patients with episodic ataxia and myokymia as a de novo heterozygous change (PMID: 26395884), and as inherited in cases with multiple similarly affected family members (PMID: 10355668, 10414318, 19779067). The clinical presentations of individuals with the p.Thr226Arg is highly variable and has included complex partial epilepsy and apneic events in infancy (PMID: 10355668). Functional studies suggest the p.Thr226Arg exerts a dominant negative effect on potassium channel function and may impair neuronal repolarization (PMID: 10355668, 10414318, 11773313). An in-vitro study of this variant in rat neurons detected no effect on neuronal excitability; however, it identified increased neurotransmitter release (PMID: 19779067). Other pathogenic variants have been observed at this amino acid residue including p.Thr226Met (PMID: 8871592) and p.Thr226Lys (PMID: 17136396, 22965560). The c.677C>G (p.Thr226Arg) variant is absent from the gnomAD population database and thus is presumed to be rare. The c.677C>G (p.Thr226Arg) variant affects a highly conserved amino acid and is predicted by multiple in silico tools to have a deleterious effect on protein function. Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the available evidence, the c.677C>G (p.Thr226Arg) variant is classified as Pathogenic. -
not provided Pathogenic:2
Functional studies indicated that T226R results in a decrease in voltage activated current and cause a dominant negative effect on potassium channel function (PMID: 10355668, 10414318); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 17395136, 11773313, 10414318, 19779067, 11026449, 15351427, 10355668, 26395884) -
PP3, PM1, PM2, PM6, PS3, PS4 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at